Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.8 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.122.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.5.6 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.440NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.23.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.104 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.198NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.17.1 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.375NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.626NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.629NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.61 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.524NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.15.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.59 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBRNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.193NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.68 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.16.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.5.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.84 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.525NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.480NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used